GSK to focus on 20 brands, 5 disease segments to drive India growth
After two consecutive years of lackluster performance on account of GST rollout, competition and price control, GSK sales rose 8 percent in FY19 on YoY basis to Rs 3128 crore.
Mon, 15 Jul 2019 21:03:06 +0530
